Riskpilot← Back to searchSign inGet full accessProteinera Holding AB
ABActiveOrg 5591326144Österlånggatan 14Sports and recreation education · NACE 8551Est. 20170 employees
Revenue 2024
SEK 15K
-98% vs 2023
EBITDA margin
-3764.5%
-338% vs 2023
Equity ratio
87.6%
Financial strength
Net profit 2024
SEK 826K
-38% vs 2023
| Revenue | SEK 15K | -98% |
| EBITDA | SEK -570K | -338% |
| Net profit | SEK 826K | -38% |
| Total assets | SEK 3,5M | +25% |
| Equity | SEK 3,1M | +25% |
| Employees | 0 | — |
Legal name
Proteinera Holding AB
Org number
5591326144
Legal form
Aktiebolag
NACE code
8551 · Sports and recreation education
Founded
7 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta aktier och andelar i dotter- och intressebolag. Bolaget skall även förvalta investeringar inom bioteknisk industri och patent. Vidare skall bolaget hålla föreläsningar inom medicin, yoga och hälsa, hålla i utbildningar och kurser inom dessa områden samt därmed förenlig verksamhet.
Address
Österlånggatan 14
Email
parnor@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 830 | 15 |
| Staff expenses | — | — | −12 | −21 | −10 |
| EBITDA | −56 | −142 | −157 | 239 | −570 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −56 | −142 | −157 | 239 | −570 |
| Net financials | 408 | 663 | 767 | 1 097 | 1 396 |
| Profit before tax | 352 | 521 | 610 | 1 336 | 826 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 352 | 521 | 610 | 1 336 | 826 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 752 | 1 195 | 1 612 | 2 837 | 3 546 |
| Equity | 576 | 913 | 1 336 | 2 480 | 3 106 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 177 | 282 | 276 | 357 | 440 |
| Total debt | 177 | 282 | 276 | 357 | 440 |
EBITDA margin
-3764.5%
This company
15.8%
Market median
-23926% vs market
20202024
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20202024
Return on equity
26.6%
This company
18.4%
Market median
+45% vs market
20202024
Net profit margin
5453.2%
This company
8.1%
Market median
+67223% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PL Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Proteinera Holding AB 
Biotarget Engagement Interest Group ABBoard members of Proteinera Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Lennart Nordlund | Chief Executive Officer | 0 companies |
| Lena Birgitta Lindgren | Deputy Board Member | 0 companies |